JP2023549675A5 - - Google Patents
Info
- Publication number
- JP2023549675A5 JP2023549675A5 JP2023526000A JP2023526000A JP2023549675A5 JP 2023549675 A5 JP2023549675 A5 JP 2023549675A5 JP 2023526000 A JP2023526000 A JP 2023526000A JP 2023526000 A JP2023526000 A JP 2023526000A JP 2023549675 A5 JP2023549675 A5 JP 2023549675A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- sars
- composition
- lipid
- administration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063108980P | 2020-11-03 | 2020-11-03 | |
| US63/108,980 | 2020-11-03 | ||
| PCT/US2021/057825 WO2022098701A1 (en) | 2020-11-03 | 2021-11-03 | Treatment and prevention of conditions associated with respiratory diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023549675A JP2023549675A (ja) | 2023-11-29 |
| JP2023549675A5 true JP2023549675A5 (cg-RX-API-DMAC10.html) | 2024-11-12 |
Family
ID=81458208
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023526000A Pending JP2023549675A (ja) | 2020-11-03 | 2021-11-03 | 呼吸器疾患に関連する状態の治療および予防 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20250195638A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP4240329A4 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2023549675A (cg-RX-API-DMAC10.html) |
| KR (1) | KR20230104640A (cg-RX-API-DMAC10.html) |
| CN (2) | CN116669708A (cg-RX-API-DMAC10.html) |
| AU (1) | AU2021373711A1 (cg-RX-API-DMAC10.html) |
| CA (1) | CA3196661A1 (cg-RX-API-DMAC10.html) |
| WO (1) | WO2022098701A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116669708A (zh) * | 2020-07-22 | 2023-08-29 | 休斯敦大学系统 | 呼吸系统疾病相关病症的治疗和预防 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3471778A4 (en) * | 2016-06-20 | 2020-02-19 | The Regents of The University of Michigan | COMPOSITIONS AND METHOD FOR DELIVERING BIOMACROMOLECOLIC ACTIVE SUBSTANCES |
| CN106667914B (zh) * | 2017-03-13 | 2022-02-01 | 杭州星鳌生物科技有限公司 | 靶向脂质体-环二核苷酸的组成、制备方法及其在抗肿瘤中的应用 |
| CN106727331B (zh) * | 2017-03-13 | 2022-02-01 | 杭州星鳌生物科技有限公司 | 免疫脂质体-环二核苷酸的组成、制备方法及其在抗肿瘤中的应用 |
| KR101982710B1 (ko) * | 2017-03-17 | 2019-05-28 | 주식회사 큐라티스 | 스팅 작용자를 포함하는 면역항원보강제 및 백신 조성물 |
| TW202003032A (zh) * | 2018-03-23 | 2020-01-16 | 美商科迪亞克生物科學公司 | 包含s t i n g 促效劑之胞外囊泡 |
| CN111187354B (zh) * | 2020-02-20 | 2020-11-27 | 北京新创生物工程有限公司 | 新型冠状病毒(SARS-CoV-2)IgM/IgG抗体检测试剂盒 |
| CN111303254A (zh) * | 2020-02-20 | 2020-06-19 | 北京新创生物工程有限公司 | 新型冠状病毒(SARS-CoV-2)抗原检测试剂盒 |
| CN113456810A (zh) * | 2020-03-30 | 2021-10-01 | 杭州星鳌生物科技有限公司 | 一种新型抗新冠病毒治疗性疫苗及其制备方法和应用 |
| CN116669708A (zh) * | 2020-07-22 | 2023-08-29 | 休斯敦大学系统 | 呼吸系统疾病相关病症的治疗和预防 |
-
2021
- 2021-07-22 CN CN202180064648.3A patent/CN116669708A/zh active Pending
- 2021-11-03 CA CA3196661A patent/CA3196661A1/en active Pending
- 2021-11-03 KR KR1020237017850A patent/KR20230104640A/ko active Pending
- 2021-11-03 AU AU2021373711A patent/AU2021373711A1/en active Pending
- 2021-11-03 US US18/034,312 patent/US20250195638A1/en active Pending
- 2021-11-03 JP JP2023526000A patent/JP2023549675A/ja active Pending
- 2021-11-03 WO PCT/US2021/057825 patent/WO2022098701A1/en not_active Ceased
- 2021-11-03 CN CN202180089023.2A patent/CN116806146A/zh active Pending
- 2021-11-03 EP EP21889949.0A patent/EP4240329A4/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2184067B1 (en) | Severe acute respiratory syndrome DNA vaccine compositions and methods of use | |
| Weeratna et al. | TLR agonists as vaccine adjuvants: comparison of CpG ODN and Resiquimod (R-848) | |
| JP2023513720A5 (cg-RX-API-DMAC10.html) | ||
| JP5331340B2 (ja) | インフルエンザウィルスワクチン組成物、及びその使用方法 | |
| US7504107B2 (en) | Methods of priming the immunogenic activity of vaccines useful for eliciting a protective immune response | |
| KR20090109122A (ko) | 암의 치료제 | |
| EP2961846A1 (en) | Crimean-congo haemorrhagic fever virus antigenic composition | |
| CN117050986B (zh) | 具有免疫刺激活性的CpG寡聚核苷酸及其用途 | |
| JP2023535405A5 (cg-RX-API-DMAC10.html) | ||
| KR101751376B1 (ko) | 점막 백신 | |
| KR102190180B1 (ko) | Dna 백신 | |
| JP2001524934A (ja) | 遺伝子治療ウイルスベクターの投与に対して哺乳類罹患動物を寛容化する方法 | |
| CN116568309B (zh) | 一种用于预防或治疗慢性乙型肝炎的药物组合制剂及其用途以及组合制剂试剂盒 | |
| Verthelyi | Adjuvant properties of CpG oligonucleotides in primates | |
| EP4175666A1 (en) | A dna plasmid sars-coronavirus-2/covid-19 vaccine | |
| CN100509056C (zh) | 包含作为佐剂的i型ifn的疫苗和涉及它们的方法 | |
| JP7370983B2 (ja) | ヘンドラウイルス感染症及びニパウイルス感染症に対するワクチン | |
| US20230321230A1 (en) | Compositions and Methods for Adjuvanted Vaccines | |
| RU2823677C2 (ru) | Cpg амфифилы и их применения | |
| Oberemok et al. | Adjuvant oligonucleotide vaccine increases survival of transgenic mice [B6. Cg-Tg (K18-ACE2) 2] | |
| US20230390384A1 (en) | Recombinant covid-19 vaccine composition comprising lipopeptide and poly (i:c) adjuvant, and use thereof | |
| HK40102335A (en) | Vaccines against hendra and nipah virus infection | |
| KR20250113423A (ko) | 안정화된 백신 | |
| TW202203970A (zh) | 靶向冠狀病毒的IgY免疫球蛋白、其製備方法、及其使用方法 | |
| Hamdy et al. | Nanotechnology for cancer vaccine delivery |